
Dr Remco Jan Geukes Foppen
Remco Jan Geukes Foppen, PhD, is an AI and life sciences expert specialising in the pharmaceutical sector and founder of Explainambiguity. With a global perspective, he integrates and implements AI-driven strategies that impact business decisions; always considering the human element. His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. Remco Jan Geukes Foppen’s academic background includes a PhD in biology and a master’s degree in chemistry, both from the University of Amsterdam.
Contact info
- Website:
- https://www.explainambiguity.eu/
ArticleThe map and compass: integrating BD&L early to de-risk drug discovery
In drug discovery, great science alone is not enough because commercial viability ultimately decides which programmes survive and attract partners. This Q&A explores how integrating Business Development and Licensing (BD&L) from the earliest stages can guide R&D strategy, sharpen decisions and de-risk the path to market.


